Cargando…
Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy
TGF-β pathway is being extensively evaluated as a potential therapeutic target. The transforming growth factor-β (TGF-β) signaling pathway has the dual role in both tumor suppression and tumor promotion. To design cancer therapeutics successfully, it is important to understand TGF-β related function...
Autores principales: | Sheen, Yhun Yhong, Kim, Min-Jin, Park, Sang-A, Park, So-Yeon, Nam, Jeong-Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825194/ https://www.ncbi.nlm.nih.gov/pubmed/24244818 http://dx.doi.org/10.4062/biomolther.2013.072 |
Ejemplares similares
-
TIMP-1 mediates TGF-β-dependent crosstalk between hepatic stellate and cancer cells via FAK signaling
por: Park, Sang-A, et al.
Publicado: (2015) -
Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells
por: Park, So-Yeon, et al.
Publicado: (2015) -
Radiotherapy-induced oxidative stress and fibrosis in breast cancer are suppressed by vactosertib, a novel, orally bioavailable TGF-β/ALK5 inhibitor
por: Park, Jiyoung, et al.
Publicado: (2022) -
Novel oral transforming growth factor‐β signaling inhibitor EW‐7197 eradicates CML‐initiating cells
por: Naka, Kazuhito, et al.
Publicado: (2016) -
Anti-Cancer Effect of 3-(4-dimethylamino phenyl)-N-hydroxy-2-propenamide in MCF-7 Human Breast Cancer
por: Min, Kyung Nan, et al.
Publicado: (2012)